| Involvement of the TCF3 gene in 19p13 rearrangements and in identifying novel and cryptic TCF3 translocations and also acts as a tumor suppressor gene in b-cell precursor acute lymphoblastic leukemia. | leukemia, |
| MiR-138 may be a tumor suppressor and potential prognostic biomarker in cervical cancer. Its downstream target, TCF3, may also regulate cancer development in a reverse manner as miR-138. | cervical, |
| E2A exhibits a tumor suppressor function in human lymphoid cells. | None |
| We conclude that inactivation of TCF3 contributes to oncogenic program of classical Hodgkin lymphoma | lymphoma, |
| SLUG, a ces-1-related zinc finger transcription factor gene with antiapoptotic activity, is a downstream target of the E2A-HLF oncoprotein. | None |
| Regulation of annexin II by cytokine-initiated signaling pathways and E2A-HLF oncoprotein. | None |
| TEF, an antiapoptotic bZIP transcription factor related to the oncogenic E2A-HLF chimera, inhibits cell growth by down-regulating expression of the common beta chain of cytokine receptors. | None |
| Oligomeric self-association contributes to E2A-PBX1-mediated oncogenesis. | None |
| The AD1 and AD2 transactivation domains of E2A are essential for the antiapoptotic activity of the chimeric oncoprotein E2A-HLF. | None |